Shuttle Pharmaceuticals 于 2025 年 2 月 26 日 (美东时间) 发布 FY2024 Q4 财报，实际营收 0 USD，实际 EPS -99.837 USD

Brief Summary

Shuttle Pharmaceuticals reported a fourth-quarter 2024 net loss of $1,598,469 on zero revenue, resulting in an earnings per share (EPS) of -$99.837 [news].

Impact of The News

Financial Performance Overview